Exparel
Payments companies reported to CMS as associated with Exparel. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Exparel, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Exparel
These are the largest totals companies reported as associated with Exparel. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Mueller | Dallas, TX | Anesthesiology | $337,326.36 |
| Richard Teames | Fort Worth, TX | Anesthesiology | $300,164.29 |
| Jeffrey Gadsden | Durham, NC | Anesthesiology | $296,996.55 |
| Valentine Gibson | Richardson, TX | Anesthesiology | $292,443.70 |
| Ryan Mountjoy | Portland, ME | Anesthesiology | $259,922.06 |
| Jacob Hutchins | Minneapolis, MN | Anesthesiology | $245,814.57 |
| Gary Schwartz | Brooklyn, NY | Pain Medicine (Anesthesiology) | $225,380.67 |
| Vinod Dasa | Kenner, LA | Orthopaedic Surgery | $217,871.52 |
| Margaret Holtz | Marietta, GA | Anesthesiology | $213,935.31 |
| Daniel Fenton | Port St Lucie, FL | Dentist | $200,408.50 |
Prescribed Exparel?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.